Ll. Patton et Dc. Shugars, Immunologic and viral markers of HIV-1 disease progression: Implications for dentistry, J AM DENT A, 130(9), 1999, pp. 1313-1322
Background, Current medical care for patients infected with the human immun
odeficiency virus type 1, or HIV-1, involves monitoring laboratory assays f
or CD4(+) lymphocyte cell count and plasma viral load.
Types of Studies Reviewed. The authors reviewed recent medical and dental s
tudies that contribute to our current understanding of these immunologic an
d viral markers and their relevance to systemic and oral health.
Results. Dramatic reduction in plasma viral load resulting from more potent
antiretroviral drug combinations is the goal of medical management for HIV
. These protease inhibitor-containing regimens, although complex, expensive
and associated with substantial side effects, have decreased the morbidity
and mortality associated with HIV in the United States. Although reduction
in viral load can result in increases in CD4(+) counts, which restores som
e level of immune competence, a cure for AIDS has not yet been found.
Clinical Implications. Patients with low CD4(+) cell counts land often high
viral loads) are more likely to develop destructive periodontal infections
and other oral manifestations of HIV. Partial recovery of the immune syste
m after viral load reduction may affect both the prognosis and oral disease
experience of these patients.